Summary & Overview
CPT 24073: Deep Excision of Upper Arm/Elbow Tumor >5 cm
CPT code 24073 denotes surgical excision of a deep tumor in the upper arm or elbow region when the lesion exceeds 5 cm. This operative code captures complex soft-tissue tumor removal in the proximal upper extremity and is relevant for surgical oncology, orthopedic oncology, and reconstructive surgical practices. Nationally, accurate coding for large, deep tumor excisions affects claims processing, medical record classification, and resource allocation for perioperative care.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, payer coverage considerations, common modifiers used with surgical codes (listed separately), and benchmarking or reimbursement context where available. The publication summarizes typical sites of service, service descriptors, and guidance on documentation elements that support use of CPT code 24073.
This report is intended to inform hospital billing teams, surgical practices, and policy analysts about the clinical scope and administrative considerations tied to CPT code 24073, including expected places of service and the primary clinical scenario that justifies use of this code. Data not available in the input is noted where relevant.
Billing Code Overview
CPT code 24073 describes the surgical removal of a tumor larger than 5 cm located deep in the upper arm and elbow region. This procedure involves excision of a deep-seated neoplasm in the proximal upper extremity and may require dissection through muscular and fascial planes.
-
Service type: Surgical tumor excision of the upper arm/elbow (deep tissue)
-
Typical site of service: Hospital operating room or ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient presents with a deep soft-tissue mass in the upper arm (brachial region) that has grown over several months and measures greater than 5 cm on MRI. Imaging suggests a deep-seated neoplasm adjacent to the neurovascular bundle and muscle fascia. The patient is evaluated in an outpatient surgical clinic by an orthopedic oncologist or general surgical oncologist. Preoperative steps include history and physical, focused neurologic and vascular exam of the affected extremity, cross-sectional imaging (MRI with contrast), and often a core needle biopsy with pathology review confirming a primary soft-tissue tumor or suspicious lesion. The patient is scheduled for an operative resection under general anesthesia in an ambulatory surgery center or hospital operating room. Intraoperative workflow includes surgical exposure of the deep upper arm or elbow region, careful dissection around neurovascular structures, en bloc removal of the tumor greater than 5 cm, hemostasis, possible intraoperative frozen section for margin assessment, and layered closure. Postoperative care includes monitoring in PACU, pain control, neurovascular checks, wound care instructions, and pathology follow-up for margins and further oncologic planning (adjuvant radiation or medical oncology referral) if indicated. Typical sites of service are an operating room in a hospital or an ambulatory surgical center. Typical providers: orthopedic oncologist, surgical oncologist, or general surgeon with soft-tissue tumor expertise.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |